133 related articles for article (PubMed ID: 7680102)
21. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
22. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1.
Anwar WA; Khalil MM; Wild CP
Mutat Res; 1994 Jul; 322(1):61-7. PubMed ID: 7517505
[TBL] [Abstract][Full Text] [Related]
23. Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures.
Appleton BS; Goetchius MP; Campbell TC
Cancer Res; 1982 Sep; 42(9):3659-62. PubMed ID: 6179606
[TBL] [Abstract][Full Text] [Related]
24. Intercellular variation in levels of adducts of aflatoxin B1 and G1 in DNA from rat tissues: a quantitative immunocytochemical study.
Wild CP; Montesano R; Van Benthem J; Scherer E; Den Engelse L
J Cancer Res Clin Oncol; 1990; 116(2):134-40. PubMed ID: 2108967
[TBL] [Abstract][Full Text] [Related]
25. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report.
Lee HS; Sarosi I; Vyas GN
Gastroenterology; 1989 Nov; 97(5):1281-7. PubMed ID: 2551766
[TBL] [Abstract][Full Text] [Related]
26. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
27. Liver DNA adducts in methyl-deficient rats administered a single dose of aflatoxin B1.
Mehta R; Laver GW; Stapley R; McMullen E
Carcinogenesis; 1992 Jul; 13(7):1241-7. PubMed ID: 1638693
[TBL] [Abstract][Full Text] [Related]
28. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
Gross-Steinmeyer K; Eaton DL
Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
[TBL] [Abstract][Full Text] [Related]
29. Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liver.
Croy RG; Nixon JE; Sinnhuber RO; Wogan GN
Carcinogenesis; 1980; 1(11):903-9. PubMed ID: 11219843
[TBL] [Abstract][Full Text] [Related]
30. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
31. An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.
Pottenger LH; Andrews LS; Bachman AN; Boogaard PJ; Cadet J; Embry MR; Farmer PB; Himmelstein MW; Jarabek AM; Martin EA; Mauthe RJ; Persaud R; Preston RJ; Schoeny R; Skare J; Swenberg JA; Williams GM; Zeiger E; Zhang F; Kim JH
Crit Rev Toxicol; 2014 Apr; 44(4):348-91. PubMed ID: 24494825
[TBL] [Abstract][Full Text] [Related]
32. Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats.
Bennett RA; Essigmann JM; Wogan GN
Cancer Res; 1981 Feb; 41(2):650-4. PubMed ID: 6778611
[TBL] [Abstract][Full Text] [Related]
33. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
[TBL] [Abstract][Full Text] [Related]
34. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout.
Goeger DE; Shelton DW; Hendricks JD; Pereira C; Bailey GS
Carcinogenesis; 1988 Oct; 9(10):1793-800. PubMed ID: 3139317
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat.
Bedard LL; Alessi M; Davey S; Massey TE
Cancer Res; 2005 Feb; 65(4):1265-70. PubMed ID: 15735011
[TBL] [Abstract][Full Text] [Related]
36. In vivo aflatoxin B1 metabolism and hepatic DNA adduction in zebrafish (Danio rerio).
Troxel CM; Reddy AP; O'Neal PE; Hendricks JD; Bailey GS
Toxicol Appl Pharmacol; 1997 Mar; 143(1):213-20. PubMed ID: 9073610
[TBL] [Abstract][Full Text] [Related]
37. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
Groopman JD
IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672
[TBL] [Abstract][Full Text] [Related]
38. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1.
Ju H; Shim Y; Arumugam P; Song JM
Toxicol Lett; 2016 Jan; 243():31-9. PubMed ID: 26739636
[TBL] [Abstract][Full Text] [Related]
39. Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet.
Schrager TF; Newberne PM; Pikul AH; Groopman JD
Carcinogenesis; 1990 Jan; 11(1):177-80. PubMed ID: 2104783
[TBL] [Abstract][Full Text] [Related]
40. Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice.
Shupe T; Sell S
Toxicol Lett; 2004 Mar; 148(1-2):1-9. PubMed ID: 15019083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
